deltatrials
Not Yet Recruiting PHASE2 INTERVENTIONAL 1-arm NCT06082817

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

An Open-Label Pilot Study of the Pharmacokinetics and Safety of 50 Mg Oral Testosterone Undecanoate (Kyzatrex) in Menopausal Women with Low Testosterone and Hypoactive Sexual Desire Disorder

Sponsor: San Diego Sexual Medicine

Conditions Hypoactive Sexual Desire Disorder
Interventions Oral Testosterone Undecanoate
Updated 4 times since 2023 Last updated: Nov 11, 2024 Started: Jan 1, 2025 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06082817, this PHASE2 trial focuses on Hypoactive Sexual Desire Disorder and remains actively recruiting participants. Sponsored by San Diego Sexual Medicine, it has been updated 4 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotNot Yet Recruiting~Dec 2024 – present · 19 months · monthly snapshotNot Yet Recruiting

Change History

4 versions recorded

  1. Dec 2024 — Present [monthly]

    Not Yet Recruiting PHASE2

  2. Sep 2024 — Dec 2024 [monthly]

    Not Yet Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE2

  4. Nov 2023 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • San Diego Sexual Medicine
Data source: San Diego Sexual Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations